HPV Vaccine Is Cancer Prevention: Changing the Narrative to Improve Vaccination Rates

Public Health Live logo over globe

Originally Presented August 16, 2023 from 9 - 10 a.m. EDT


HPV vaccination rates are currently low in New York State and across the country. The HPV vaccine is safe and effective in preventing HPV and HPV-related cancers.  Early HPV vaccine conversations that focus on HPV-related cancer prevention have been shown to be more likely to result in HPV vaccine acceptance. This webcast will review the current state of HPV disease and present communication strategies for improving vaccination rates and preventing HPV-associated cancers.


UAlbany Video

Learn More


Jana Shaw MD, MPH
Chief Medical Officer
North Country Family Health Center
Watertown, NY

Manika Suryadevara, MD
Associate Professor of Pediatrics
SUNY Upstate Medical University
Syracuse, NY

Learning Outcome and Objectives

As a result of participation in this activity, the learners will increase and enhance knowledge and competence on how to make updated HPV vaccination recommendations using cancer prevention as a communication strategy. 

By the end of the webcast, viewers will be able to: 

  • Discuss the burden of HPV disease and related cancers
  • Explain the safety and efficacy of the HPV vaccine
  • Describe communication techniques for talking with parents or patients about the HPV vaccine
Continuing Education Credits

To Obtain Continuing Education Credits

Each participant interested in CE credits must watch the activity, complete an evaluation and post-test, which is available above under "Evaluation, Post-test for CE Credits". A score of 80% and above on the post-test will generate a certificate indicating the requested credits.

Criteria for Successful Completion: Learners must attend 100% of this activity to be awarded full continuing education credits /contact hours.


Disclosure Statements

Manika Suryadevara, MD

  • Principal Investigator - Institution receives research funding for work on vaccine confidence, HPV vaccination rates, RSV epidemiology for Merck Sharpe & Dohme Corp
  • Principal Investigator - Institution received research funding for site to be involved with clinical trials for flu treatment for Hoffman LaRoche (completed 2022)
  • Principal Investigator - Institution received research funding for site to be involved with clinical trials for RSV treatment for Janssen (completed 2022)

Jana Shaw MD, MPH

  • Consultant for Pfizer

All relevant financial relationships have been mitigated for Dr. Suryadevara and Dr. Shaw.

None of the other planners, moderator, and presenters have any financial arrangements or affiliations with any ineligible companies whose products, research or services may be discussed in this activity.

No commercial funding has been accepted for this activity. 


Continuing Medical Education Credits

The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

The School of Public Health, University at Albany designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Medical Education Credits are offered until August 31, 2026. 


Continuing Nurse Education Contact Hours

University at Albany School of Public Health is approved with distinction as a provider of nursing continuing professional development by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This offering is approved for 1.0 nursing contact hour(s).

Nursing Contact Hours are offered until March 23, 2025 


Certified Health Education Specialist Contact Hours

Sponsored by the School of Public Health, University at Albany, SUNY, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I contact education contact hours. Maximum advanced-level continuing education contact hours available are 0. Continuing Competency credits available are 1.0. Provider ID# 99086.

Continuing Education Contact Hours are offered until August 31, 2026.


Certified in Public Health

This event is sponsored by the School of Public Health, University at Albany, an approved provider of CPH Renewal Credits by the National Board of Public Health Examiners.

This offering is approved for 1.0 Certified in Public Health Renewal Credits.

CPH Renewal Credits are offered until August 31, 2026.

Evaluation, Post-Test and Certificate